Evidence suggests that dysregulation of epidermal growth factor receptor (EGFR) signaling may contribute to cancer cell proliferation, increase tumor vascularization and enhance metastasis [12] and overexpression of EGFR is associated with castration-resistant and high-risk prostate cancer, as well as prostate cancer bone metastasis [13]. This evidence concerns the gene EGFR and neoplasm.